Compound heterozygotes for hemochromatosis gene mutations: May they help to understand the pathophysiology of the disease?

Blood Cells, Molecules and Diseases

Volumn 23, Issue 2, 1997, Pages 269-276

  Aguilar Martinez, Patricia ^a   Biron, Christine ^a   Blanc, François ^a   Masmejean, Christophe ^a   Jeanjean, Philippe ^a   Michel, Henri ^a   Schved, Jean François ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

Compound heterozygotes; Hemochromatosis; HFE gene; Iron

Indexed keywords

DNA; FERRITIN; HLA ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; HEMOCHROMATOSIS; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL;

EID: 0031213527     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1997.0143     Document Type: Article

References (11)

1. 1. Feder JN, Gnirke A, Thomas W, et al. A novel MCH class I-gene is mutated in patients with hereditary hemochromatosis. Nat Genet 13:399-408, 1996.
2. 2. Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 22(16): 187-194, 1996.
3. 3. Jouanolle A-M, Gandon G, Jézéquel P, et al. Haemochromatosis and HLAH. Nat Genet 14:251-252, 1996.
4. 4. Jazwinska EC, Cullen L M, Bushfield F, et al. Haemochromatosis and HLA H. Nat Genet 14:249-250, 1996.
5. 5. Beutler E. Genetic irony behond haemochromatosis: Clinical effects of HLA-H mutations. Lancet 349:296-297, 1997.
6. 6. Beutler E, West C, Gelbart T, Felitti VJ. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Commentary. Blood Cells Mol Dis 23:145a-145b, 1997.
7. 7. Aguilar-Martinez P, Jeanjean P, Masmejean C, et al. Simple and rapid detection of the newly described mutations in the HLA H gene. Blood 89:1835-36, 1997.
8. 8. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 335:1799-1805, 1996.
9. 9. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder G. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 349:321-323, 1997.
10. 10. Feder JN, Tsuchihashi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLA-H disrupts beta 2-microglobulin interaction and cell surface expression. J Biol Chem 272:14025-14028, 1997.
11. 11. Parkkila S, Waheed A, Britton RS, et al Immunochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals a unique pattern of expression in gastointestinal tract. Proc Natl Acad Sci USA 94:2534-2539, 1997.